Showing 1311-1320 of 1626 results for "".
What to Know About the COVID-19 Pandemic
https://modernod.com/topics/business/what-to-know-about-the-covid-19-pandemic/38086/Important takeaways from public health evidence.Cornea and Contact Lens Considerations in Glaucoma
https://modernod.com/topics/contact-lenses/cornea-and-contact-lens-considerations-in-glaucoma/38070/Preventing dropout depends on addressing the ocular surface and other issues.Barriers to the Business of Myopia Management
https://modernod.com/topics/myopia/barriers-to-the-business-of-myopia-management/38054/Adopting a myopia management program requires a paradigm shift in your practice.Standard Tools and Tests for Diagnosing Diabetic Retinopathy
https://modernod.com/topics/retina/standard-tools-and-tests-fordiagnosing-diabetic-retinopathy/37942/A variety of imaging modalities can help clinicians define the level of retinopathy and make treatment and referral decisions.Comanaging Patients Before and After Glaucoma Surgery
https://modernod.com/mod-issues/2020-apr/comanaging-patients-before-and-after-glaucoma-surgery/39100/Clear communication and a firm understanding of the surgical options are integral to success.New Drugs for Dry Eye and Demodex Blepharitis
https://modernod.com/topics/ocular-surface/new-drugs-for-dry-eye-and-idemodexi-blepharitis/38625/More options, more personalized treatment for patients. Get familiar with what may end up in your toolbox.Guidelines for Managing Myopia: a Review
https://modernod.com/topics/myopia/guidelines-for-managing-myopia-a-review/38394/Developing a standard of care will improve the lives of patients.Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments
https://modernod.com/topics/glaucoma/ushering-in-a-new-treatment-paradigm-for-glaucoma-updates-on-novel-therapeutics-and-disease-modifying-treatments/38079/- Azura Ophthalmics Appoints Steven Altschuler, MD, as Chair of the Boardhttps://modernod.com/news/azura-ophthalmics-appoints-steven-altschuler-md-as-chair-of-the-board/2479486/Azura Ophthalmics announced the appointment of Steven M. Altschuler, MD, as chair of its board of directors. Dr. Altschuler brings more than 20 years of experience building, scaling, and leading health care and biotechnology companies. He currently serves as managing director of Healthcare Ventur
- OD-OS Achieves Revocation of Iridex MicroPulse Patenthttps://modernod.com/news/od-os-achieves-revocation-of-iridex-micropulse-patent/2480020/OD-OS has achieved the revocation of the MicroPulse Patent (Patent no EP1856774) by Iridex Corporation in oral proceedings at the European Patent office held last Friday in Munich, Germany according to an OD-OS news release. With its successful opposition, OD-OS has cleared the path to man